Toxoplasmosis del sistema nervioso central y VIH: revisión de la literatura

Blanca Saca; Francy Hollminn Salas Contreras; Marcia Yolanda Cobos Alvarracin

doi:10.46652/rgn.v9i42.1292

Blanca Saca Universidad Católica del Ecuador | Cuenca | Ecuador
Francy Hollminn Salas Contreras Universidad Católica del Ecuador | Cuenca | Ecuador
Marcia Yolanda Cobos Alvarracin Universidad Católica del Ecuador | Cuenca | Ecuador

DOI: https://doi.org/10.46652/rgn.v9i42.1292

Palavras-chave: Sistema Nervoso Central; cérebro; Classificação; Toxoplasmose; HIV; morte

Resumo

Na odontologia, avanços notáveis foram feitos nas últimas décadas com foco na eficiência terapêutica e na melhoria da experiência do paciente. Um dos principais desafios nesse campo é acelerar a movimentação dentária, o que pode reduzir a duração dos tratamentos ortodônticos e minimizar o impacto negativo nos tecidos periodontais. Analisar a aplicação da osteotomia e da corticotomia na ortodontia acelerada. Para realizar esta revisão, foi feita uma busca exaustiva em bancos de dados científicos de 2018 a 2023 em inglês e espanhol, usando termos controlados e descritores relacionados à osteotomia, corticotomia e movimentação dentária acelerada. Foram aplicados critérios de inclusão e exclusão. Os 12 estudos revisados mostram que tanto a corticotomia quanto a osteotomia têm um impacto positivo na aceleração do movimento dentário, reduzindo a densidade óssea cortical e diminuindo a resistência ao movimento dentário; a eficácia dessas técnicas pode variar. Tanto a corticotomia quanto a osteotomia são técnicas cirúrgicas valiosas na ortodontia acelerada, com a capacidade de modificar as propriedades do tecido ósseo circundante e facilitar a movimentação dentária.

Downloads

Não há dados estatísticos.

##plugins.generic.paperbuzz.metrics##

Carregando Métricas ...

Referências

Abbasi Fard, S., Khajeh, A., Khosravi, A., Mirshekar, A., Masoumi, S., Tabasi, F., Hassanzadeh, T., & Mortazavi, M. M. (2020). Fulminant and Diffuse Cerebral Toxoplasmosis as the First Manifestation of HIV Infection: A Case Presentation and Review of the Literature. The American journal of case reports, 21. https://doi.org/10.12659/AJCR.919624

Achenbach, C. (2022) HIV infection–Symptoms, diagnosis and treatment. BMJ Best Practice. https://bestpractice.bmj.com/topics/en-gb/555

Amare, A. (2021). Seizure in HIV-infected patients: clinical presentation, cause and treatment outcome in Ethiopia-a retrospective study. BMC infectious diseases, 21(1), 790. https://doi.org/10.1186/s12879-021-06497-7

Antela, A., Azcoaga, A., Sampedro, E., & Poveda, T. (2018). Prevención primaria. Enfermedades infecciosas y microbiologia clinica, 36(1), 31–34. https://doi.org/10.1016/S0213-005X(18)30244-1

Azovtseva, O. V., Viktorova, E. A., Bakulina, E. G., Shelomov, A. S., & Trofimova, T. N. (2020). Cerebral toxoplasmosis in HIV-infected patients over 2015–2018 (a case study of Russia). Epidemiology and Infection, 148.

Barros, J., & Valero, N. (2022).Toxoplasmosis y su asociación a morbimortalidad en pacientes con infección por virus de inmunodeficiencia humana. FIPCAEC, 7(4), 679–701.

Bokharaei-Salim, F., Esteghamati, A., & Khanaliha, K., (2020). Evaluation of a PCR assay for diagnosis of toxoplasmosis in serum and peripheral blood mononuclear cell among HIV/AIDS patients. J Parasit Dis, 44(1),159–65.

Bokova, E., Kuptsova, M., Gorozhanina, E., Bogomolov, D., Berechikidze, I., & Grinev, A. (2020). Peculiarities of interaction in the “parasite-host” system in hiv-infected patients with toxoplasmosis: literature and clinical case review. Georgian medical news, (301), 130–136.

Bondarenko, A. V., Katsapov, D. V., Gavrylov, A. V., Didova, T. V., & Nahornyi, I. A. (2020). Immunodiagnostics of cerebral toxoplasmosis depending on permeability of blood-brain barrier. Wiadomosci lekarskie, 73(2), 285–288.

Bracho, A., & Zamora, J. (2023). Toxoplasmosis cerebral en pacientes con VIH/SIDA de la Fundación S.O.G.A. Portoviejo. QUALIKAY, 7(2).

Bravo, V., & Latorre, M. (2020). Una revisión actualizada de Toxoplasma gondii en Ecuador: dónde estamos y a dónde vamos desde aquí. Revista Dilemas Contemporáneos, VIII(1).

Chachay E. (2023). Infección por el Virus de la Inmunodeficiencia humana VIH. Manual MSD. https://lc.cx/GGCHzW

De Faria Junior, G. M., Murata, F. H. A., Lorenzi, H. A., Castro, B. B. P., Assoni, L. C. P., Ayo, C. M., Brandão, C. C., & de Mattos, L. C. (2021). The Role of microRNAs in the Infection by T. gondii in Humans. Frontiers in cellular and infection microbiology, 11. https://doi.org/10.3389/fcimb.2021.670548

Dian, S., Ganiem, A., & Ekawardhani, S. (2023). Cerebral toxoplasmosis in HIV-infected patients: a review. Pathog Glob Health, 117(1),14.

Diogo, M. C., Glatter, S., & Binder, J. (2020). The MRI spectrum of congenital cytomegalovirus infection. Prenat Diagn, 40(1), 110–24.

Durieux, M. F., Lopez, J. G., Banjari, M., Passebosc-Faure, K., Brenier-Pinchart, M. P., Paris, L., Gargala, G., Berthier, S., Bonhomme, J., Chemla, C., Villena, I., Flori, P., Fréalle, E., L’Ollivier, C., Lussac-Sorton, F., Montoya, J. G., Cateau, E., Pomares, C., Simon, L., Quinio, D., … Dardé, M. L. (2022). Toxoplasmosis in patients with an autoimmune disease and immunosuppressive agents: A multicenter study and literature review. PLoS neglected tropical diseases, 16(8). https://doi.org/10.1371/journal.pntd.0010691

Dwinata, M., Widyadharma, E., & Dewi, P. (2021). Risk factors of cerebral toxoplasmosis in HIV patients: A systematic review. Romanian Journal of Neurology, 20(3), 305.

Flores, A., Alanoca, B., & Vargas, T. (2023). Seroprevalencia y factores de riesgo de Toxoplasma gondii en Personas que Viven con VIH/SIDA (PVVS) en el departamento de Cochabamba, Bolivia: Seroprevalencia y factores de riesgo de Toxoplasma gondii en personas con VIH. Gaceta Médica Boliviana, 46(2), 63–7.

Gandhi, R. (2023, 31 de marzo). Toxoplasmosis in patients with HIV. UpToDate. https://lc.cx/N7Ytgx

Gutierrez-Loli, R., Ferradas, C., & Diestra, A. (2019). Development of a Novel Protocol Based on Blood Clot to Improve the Sensitivity of qPCR Detection of Toxoplasma gondii in Peripheral Blood Specimens. Am J Trop Med Hyg, 100(1), 83–9.

Guzmán C, Bajaña A. (2020). Alteraciones neurológicas por toxoplasmosis cerebral en pacientes con infección por VIH/Sida en el Hospital de Infectología [Tesis de licenciatura, Universidad de Guayaquil].

Hassana, D., Hadisaputro, S., & Udji, M. (2021). Toxoplasmosis and Cerebral Toxoplasmosis in HIV/AIDS Patients in Kariadi Hospital, Semarang. Journal Epidemiologi Kesehatan Komunitas, 6(1), 213–7.

Hosoda, T., Mikita, K., Ito, M., Nagasaki, H., & Sakamoto, M. (2021). Cerebral toxoplasmosis with multiple hemorrhage lesions in an HIV infected patient: A case report and literature review. Parasitology international, 81. https://doi.org/10.1016/j.parint.2020.102280

Konstantinovic, N., Guegan, H., Stäjner, T., Belaz, S., & Robert-Gangneux, F. (2019). Treatment of toxoplasmosis: Current options and future perspectives. Food and waterborne parasitology, 15. https://doi.org/10.1016/j.fawpar.2019.e00036

Lapinskas, P., Ben, R. (2019). Perspective on current and emerging drugs in the treatment of acute and chronic toxoplasmosis. Postgrad Med, 131(8), 589–96.

Liu, E., Kakodkar, P., & Toyota, P. (2023). P.139 Cerebral toxoplasmosis in an HIV-negative patient. Journal of Neurological Sciences, 50(2), 94.

Marra, C. (2018). Chapter 9–Central nervous system infection with Toxoplasma gondii. Handbook of Clinical Neurology, 152, 117-122

Muchamad, G., & Sofro, M. (2023). Case Report: Lesson Learned from Delayed Definitive Treatment of Stage 4 HIV Patient with Cerebral Toxoplasmosis – A Case Report. Journal Kedokteran Diponegoro, 12(1), 26-29.

Pascanus, P., & Sri, Y. (2023). Neuropsychiatric Symptoms in Cerebral Toxoplasmosis with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS): Case Report. International journal of research and review, 10(1), 413-418.

Pellegrino, D., Gryschek, R., de Oliveira, A. C. P., Marcusso, R., Correia, A., & Vidal, J. E. (2019). Efficacy and safety of trimethoprim-sulfamethoxazole in HIV-infected patients with cerebral toxoplasmosis in Brazil: a single-arm open-label clinical trial. International journal of STD & AIDS, 30(12), 1156–1162. https://doi.org/10.1177/0956462419865829

Sax, P. (2024, 26 de agosto). Overview of prevention of opportunistic infections in patients with HIV. UpToDate. https://lc.cx/frG68T

Schlüter, D., & Barragan, A. (2019). Advances and Challenges in Understanding Cerebral Toxoplasmosis. Frontiers in immunology, 10, 242. https://doi.org/10.3389/fimmu.2019.00242

Seksyaev, N., Karakulova, Y., & Sosnin, D. (2023). Clinical manifestations and neuron-specific enolase cerebrospinal fluid concentration in HIV/AIDS patients with cerebral toxoplasmosis. Rossijskij nevrologičeskij žurnal, 28(2):25–30.

Smiljkovic, M., Renaud, C., & Tapiero, B. (2019). Head ultrasound, CT or MRI? the choice of neuroimaging in the assessment of infants with congenital cytomegalovirus infection. BMC Pediatr, 19(1), 1–6. Disponible

Tan, I. L., Smith, B. R., Von Geldern, G., Mateen, F. J., McArthur, J. C. (2012). HIV-associated opportunistic infections of the CNS. Lancet Neurol, 11(7), 605-17.

Tumbaco, A. (2021). VIH/Sida en Ecuador: Epidemiología, comorbilidades, mutaciones y resistencia a antirretrovirales. Revista científica, 7, 341–54.

Van Heuvel, Y., Schatz, S., Rosengarten, J. F., Stitz, J. (2022). Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine. Toxins, 14(2), 138. https://doi.org/10.3390/toxins14020138

Vélez, F., & Tobar, R. (2020). Boletín Anual de VIH/sida Ecuador Estrategia Nacional de VIH/sida-ITS. Ministerio de Salud Pública.

Vidal, J. E. (2019). HIV-Related Cerebral Toxoplasmosis Revisited: Current Concepts and Controversies of an Old Disease. Journal of the International Association of Providers of AIDS Care (JIAPAC),18.

Vieira, P. C., Waghabi, M. C., Beghini, D. G., Predes, D., Abreu, J. G., Mouly, V., Butler-Browne, G., Barbosa, H. S., & Adesse, D. (2019). Toxoplasma gondii Impairs Myogenesis in vitro, With Changes in Myogenic Regulatory Factors, Altered Host Cell Proliferation and Secretory Profile. Frontiers in cellular and infection microbiology, 9, 395. https://doi.org/10.3389/fcimb.2019.00395

Wesołowski, R., Pawłowska, M., Smoguła, M. (2023). Advances and Challenges in Diagnostics of Toxoplasmosis in HIV-Infected Patients. Pathogens, 12(1), 110.

Wibawani, R., Soeprijanto, B., Ferriastuti, W., & Triyono, E. A. (2019). Head Computed Tomography Images of HIV/AIDS Patients with Suspected Cerebral Toxoplasmosis in Dr. Soetomo General Hospital Surabaya. Biomolecular and Health Science Journal, 2(1), 21–26. https://doi.org/10.20473/bhsj.v2i1.13343

Wood, B. (2023, 15 de febrero). The natural history and clinical features of HIV infection in adults and adolescents. UpToDate. https://lc.cx/W3ll2C

Xu, M., Gao, J., Li, S., Zeng, M., Wu, J., & Luo, M. (2020). Metagenomic analysis and identification of emerging pathogens in blood from healthy donors. Scientific reports, 10(1), 15809. https://doi.org/10.1038/s41598-020-72808-8

Yenilmez, E., & Çetinkaya, R. A. (2019). Difference in Toxoplasma gondii Seroprevalence Rates Due to Low and High CD4 Counts in Patients with HIV/AIDS. Turkiye parazitolojii dergisi, 43(1), 1–7. https://doi.org/10.4274/tpd.galenos.2019.6457